Pregnancy drug dosing study aims to stop syphilis in newborns
NCT ID NCT05309928
First seen Jan 10, 2026 · Last updated May 01, 2026 · Updated 18 times
Summary
This study looked at how the antibiotic amoxicillin is processed in the body during pregnancy. The goal is to find the right dose to prevent congenital syphilis, which can harm babies. Thirteen pregnant women in their second or third trimester took part. Researchers measured drug levels in the mother's blood and the baby's cord blood to understand how much reaches the baby.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY RELATED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UAB
Birmingham, Alabama, 35294, United States
Conditions
Explore the condition pages connected to this study.